Reported Tuberculosis in the United States, 2016

Print
Related Pages
The dining hall of Boyd Sanatorium in Dripping Springs, part of the Organ Mountains–Desert Peaks National Monument in Doña Ana County, New Mexico, USA

PDF [12MB]

Surveillance Report

Surveillance Data Training: Report of Verified Case of Tuberculosis

NOTE: Click the links below to show or hide the tables for each section.

  • Table 1. Tuberculosis Cases, Case Rates per 100,000 Population, Deaths, and Death Rates per 100,000 Population, and Percent Change: United States, 1953–2016 [PDF – 222 KB]
  • Table 2. Tuberculosis Cases, Percentages, and Case Rates per 100,000 Population by Hispanic Ethnicity and Non-Hispanic Race: United States, 1993–2016 [PDF – 393 KB]
  • Table 3. Tuberculosis Cases and Percentages by Hispanic Ethnicity and Non-Hispanic Race, and by Origin of Birth: United States, 1993–2016 [PDF – 482 KB]
  • Table 4. Tuberculosis Cases, Percentages, and Case Rates per 100,000 Population by Age Group: United States, 1993–2016 [PDF – 443 KB]
  • Table 5. Tuberculosis Cases, Percentages, and Case Rates per 100,000 Population by Origin of Birth: United States, 1993–2016 [PDF – 203 KB]
  • Table 6. Tuberculosis Cases and Percentages Among Non-U.S.–Born Persons by the Top 30 Countries of Birth: United States, 2012–2016 [PDF – 322 KB]
  • Table 7. Tuberculosis Cases and Percentages by Case Verification Criterion and Site of Disease: United States, 1993–2016 [PDF – 360 KB]
  • Table 8. Tuberculosis Cases and Percentages, by Resistance to Isoniazid (INH), Origin of Birth, and Previous History of TB: United States, 1993–2016 [PDF – 339 KB]
  • Table 9. Tuberculosis Cases and Percentages, by Multidrug Resistance (MDR), Origin of Birth, and Previous History of TB: United States, 1993–2016 [PDF – 216 KB]
  • Table 10. Percentages of Tuberculosis Cases, by Initial Drug Regimen, Use of Directly Observed Therapy (DOT), and Completion of Therapy (COT): United States, 1993–2016 [PDF – 202 KB]
  • Table 11. Tuberculosis Cases and Percentages Among Persons with HIV Test Results and with HIV Coinfection, by Age Group: United States, 1993–2016 [PDF – 428 KB]
  • Table 12. Tuberculosis Cases and Percentages, by Reason Tuberculosis Therapy Was Stopped: United States, 1993–2014 [PDF – 429 KB]
  • Table 13. National Tuberculosis Genotyping Surveillance Coverage: United States, 2004–2016 [PDF – 239 KB]
  • Table 14. National Tuberculosis Genotyping Surveillance Coverage: United States-Affiliated Areas, 2004–2016 [PDF – 233 KB]
  • Table 15. Genotyped Tuberculosis Cases with Mycobacterium bovis by Origin of Birth: United States, 2004–2016  [PDF – 250 KB]
  • Table 16. Tuberculosis Cases and Percentages Among Non-U.S.–Born Persons, by the Top 30 Countries of Birth and Years in the United States Before TB Diagnosis: United States, 2016  [PDF – 534 KB]
  • Table 17. Tuberculosis Cases and Rates per 100,000 Population, by Hispanic Ethnicity and Non-Hispanic Race, Sex, and Age Group: United States, 2016  [PDF – 340 KB]
  • Table 18. Tuberculosis Cases Among U.S.-Born Persons, by Hispanic Ethnicity and Non-Hispanic Race, Sex, and Age Group: United States, 2016  [PDF – 221 KB]
  • Table 19. Tuberculosis Cases Among Non-U.S.–Born Persons, by Hispanic Ethnicity and Non-Hispanic Race, Sex, and Age Group: United States, 2016  [PDF – 223 KB]
  • Table 20. Tuberculosis Cases Among Non-U.S.–Born Persons, by WHO Region and Country of Birth: United States, 2016  [PDF – 271 KB]
  • Table 21. Tuberculosis Risk Factors, by Origin and Race/Ethnicity: United States, 2016  [PDF – 262 KB]
  • Table 22. Characteristics of Tuberculosis Cases in GENType Clusters, by Alert Levels Based on Log-Likelihood Ratios (LLR): United States, 2014–2016  [PDF – 583 KB]
  • Table 23. Tuberculosis Cases and Clusters, by Cluster Size: United States, 2014–2016  [PDF – 234 KB]
  • Table 24. Twenty-Five Most Frequently Reported GENTypes Among Genotyped Tuberculosis Cases: United States, 2014–2016  [PDF – 259 KB]
  • Table 25. Five Most Frequently Reported GENTypes Among Genotyped Tuberculosis Cases: United States-Affiliated Areas, 2014–2016  [PDF – 208 KB]
  • Table 26. Tuberculosis Cases and Percentages by Reason Tuberculosis Therapy Was Stopped and Type of Move: United States, 2014  [PDF – 227 KB]
  • Table 27. Deaths Among Reported Tuberculosis Cases, by Age Group: United States, 2014  [PDF – 212 KB]
  • Table 28. Sputum Culture Conversion, by Age Group: United States, 2014  [PDF – 250 KB]
  • Table 29. Tuberculosis Cases and Case Rates per 100,000 Population: Reporting Areas, 2016 and 2015 [PDF – 263 KB]
  • Table 30. Tuberculosis Cases and Case Rates per 100,000 Population, Ranked and Grouped by Number of Cases: United States and the District of Columbia, 2016 and 2015 [PDF – 245 KB]
  • Table 31. Tuberculosis Cases and Percentages, by Age Group: Reporting Areas, 2016 [PDF – 543 KB]
  • Table 32. Tuberculosis Cases and Percentages by Hispanic Ethnicity and Non-Hispanic Race: Reporting Areas, 2016 [PDF – 516 KB]
  • Table 33. Tuberculosis Cases and Percentages, U.S.-Born and Non-U.S.–Born Persons: Reporting Areas, 2016 [PDF – 229 KB]
  • Table 34. Tuberculosis Cases and Percentages Among Non-U.S.–Born Persons, by Top Seven Countries of Birth: Reporting Areas, 2016 [PDF – 364 KB]
  • Table 35. Tuberculosis Cases and Percentages Among Non-U.S.–Born Persons, by Immigration Status at First Entry: Reporting Areas, 2016 [PDF – 475 KB]
  • Table 36. Tuberculosis Cases and Percentages Among Non-U.S.–Born Persons, by Number of Years in the United States: Reporting Areas, 2016 [PDF – 414 KB]
  • Table 37. Tuberculosis Cases and Percentages, by Pulmonary and Extrapulmonary Disease: Reporting Areas, 2016 [PDF – 326 KB]
  • Table 38. Extrapulmonary Tuberculosis Cases and Percentages by Site of Disease: Reporting Areas, 2016 [PDF – 292 KB]
  • Table 39. Tuberculosis Risk Factors: Reporting Areas, 2016 [PDF – 587 KB]
  • Table 40. Primary Reason for Tuberculosis Evaluation: Reporting Areas, 2016 [PDF – 551 KB]
  • Table 41. Tuberculosis Cases and Percentages, by Residence in and Type of Correctional Facilities, Ages ≥15 Years: Reporting Areas, 2016 [PDF – 381 KB]
  • Table 42. Tuberculosis Cases and Percentages, by Homeless Status, Ages ≥15 Years: Reporting Areas, 2016 [PDF – 231 KB]
  • Table 43. Tuberculosis Cases and Percentages, by Residence in Long–Term Care Facilities, Ages ≥15 Years: Reporting Areas, 2016 [PDF – 234 KB]
  • Table 44. Tuberculosis Cases and Percentages, by Injecting Drug Use, Ages ≥15 Years: Reporting Areas, 2016 [PDF – 210 KB]
  • Table 45. Tuberculosis Cases and Percentages, by Noninjecting Drug Use, Ages ≥15 Years: Reporting Areas, 2016 [PDF – 211 KB]
  • Table 46. Tuberculosis Cases and Percentages, by Excess Alcohol Use, Ages ≥15 Years: Reporting Areas, 2016 [PDF – 211 KB]
  • Table 47. Tuberculosis Cases and Percentages by Primary Occupation, Ages ≥15 Years: Reporting Areas, 2016 [PDF – 225 KB]
  • Table 48. Tuberculosis Cases and Percentages, by Initial Drug Regimen: Reporting Areas, 2016 [PDF – 217 KB]
  • Table 49. Culture-Positive Tuberculosis Cases and Percentages with Drug Susceptibility Results, by Resistance to Isoniazid or Multidrug Resistance: Reporting Areas, 2016 [PDF – 217 KB]
  • Table 50. Tuberculosis Cases and Percentages, by HIV Status: Reporting Areas, 2016 [PDF – 217 KB]
  • Table 51. Tuberculosis Diagnostic Tests, by Type of Laboratory: Reporting Areas, 2016 [PDF – 248 KB]
  • Table 52. Tuberculosis Genotyping Surveillance Coverage: Reporting Areas, 2016 [PDF – 208 KB]
  • Table 53. Tuberculosis Cases and Percentages, by Type of Health Care Provider: Reporting Areas, 2014 [PDF – 217 KB]
  • Table 54. Tuberculosis Cases and Percentages, by Directly Observed Therapy (DOT): Reporting Areas, 2014 [PDF – 214 KB]
  • Table 55. Tuberculosis Cases and Percentages, by Reason Therapy Was Stopped: Reporting Areas, 2014 [PDF – 240 KB]
  • Table 56. Reason Therapy Was Extended Beyond 12 Months: Reporting Areas, 2014 [PDF – 240 KB]
  • Table 57. Completion of Tuberculosis Therapy (COT) Cases and Percentages, by Hispanic Ethnicity and Non-Hispanic Race: Reporting Areas, 2014 [PDF – 254 KB]
  • Table 58. Tuberculosis Cases and Percentages, by Completion of Tuberculosis Therapy (COT): Reporting Areas, 2014 [PDF – 216 KB]
  • Table 59. Tuberculosis Cases and Percentages Among Persons Completing Therapy for Whom Therapy Was Indicated for ≤1 Year: Reporting Areas, 2010–2014 [PDF – 227 KB]
  • Table 60. Tuberculosis Cases and Case Rates per 100,000 Population: Metropolitan Statistical Areas with ≥500,000 Population, 2016 and 2015 [PDF – 392 KB]
  • Table 61. Tuberculosis Cases, by Age Group: Metropolitan Statistical Areas with ≥500,000 Population, 2016 [PDF – 502 KB]
  • Table 62. Tuberculosis Cases, by Hispanic Ethnicity and Non-Hispanic Race: Metropolitan Statistical Areas with ≥500,000 Population, 2016 [PDF – 251 KB]
  • Table 63. Tuberculosis Cases and Percentages, U.S.-Born Persons and Non-U.S.–Born Persons: Metropolitan Statistical Areas with ≥500,000 Population, 2016 [PDF – 280 KB]
  • Table 64. Tuberculosis Cases and Percentages, by Homeless Status, Ages ≥15 Years: Metropolitan Statistical Areas with ≥500,000 Population, 2016 [PDF – 261 KB]

Notes on Recent Transmission [PDF – 273 KB]

Figures

  • Figure 1. Estimated Cases Attributed to Recent Transmission of Tuberculosis, United States, 2015–2016 [JPG – 388 KB]
  • Figure 2. Estimated Percentage of Extensive Recent Transmission of Tuberculosis in Counties with ≥10 Genotyped Cases, United States, 2015–2016 [JPG – 276 KB]

Tables

  • Table 65. Counts and Percentages of Tuberculosis Cases Estimated to be Attributed to Overall and Extensive Recent Transmission: Reporting Areas, 2015–2016 [PDF – 233 KB]
  • Table 66. Counts and Percentages of Tuberculosis Cases Estimated to be Attributed to Overall and Extensive Recent Transmission: Counties with >5 Percent Estimated Extensive Recent Transmission, 2015-2016 [PDF – 201 KB]
  • Table 67. Characteristics of Tuberculosis Cases Estimated to be Attributed to Overall and Extensive Recent Transmission: United States, 2015–2016 [PDF – 264 KB]
  • Appendix A: Tuberculosis Case Definition for Public Health Surveillance [PDF – 311 KB]
  • Appendix B: Recommendations for Reporting and Counting Tuberculosis Cases [PDF – 447 KB]
  • Appendix C: National Surveillance for Severe Adverse Events Associated with Treatment for Latent Tuberculosis Infection — Reporting information [PDF – 229 KB]
  • Appendix D: Genotyping Background Information and Glossary [PDF – 310 KB]